Skip to Main Content

Paper Details

Revolutionizing DNA repair research and cancer therapy with CRISPR-Cas screens.
Nat Rev Mol Cell Biol
14
2023
CRISPR, Cas, DDR-deficiency, PARP, cancer, homologous recombination deficiencies, human
Author NameAffiliation
Stephen P JacksonCancer Research UK Cambridge Institute, University of Cambridge
Stephen P JacksonThe Gurdon Institute and Department of Biochemistry, University of Cambridge
Stephen P JacksonCancer Research UK Cambridge Institute, University of Cambridge
Stephen P JacksonThe Gurdon Institute and Department of Biochemistry, University of Cambridge
  • 1 - 4

Datasets

Release 1.2